Adrian J Hobbs

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Top Venues

British journal of pharmacology

Proceedings of the National Academy of Sciences of the United States of America

Antioxidants (Basel, Switzerland)

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Henriette Andresen, Cristina Pérez-Ternero, Jerid Robinson, Deborah M Dickey, Adrian J Hobbs, Lincoln R Potter, Finn Olav Levy, Alessandro Cataliotti, Lise Román Moltzau
Novel enhancers of guanylyl cyclase-A activity via allosteric modulation. British journal of pharmacology (2023)
Jon M Fukuto, Cristina Perez-Ternero, Jessica Zarenkiewicz, Joseph Lin, Adrian J Hobbs, John P Toscano
Hydropersulfides (RSSH) and Nitric Oxide (NO) Signaling: Possible Effects on S-Nitrosothiols (RS-NO). Antioxidants (Basel, Switzerland) 11 (1) (2022)
Cristina Perez-Ternero, Aisah A Aubdool, Raj Makwana, Gareth John Sanger, Roland H Stimson, Li F Chan, Amie J Moyes, Adrian J Hobbs
C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis. Proceedings of the National Academy of Sciences of the United States of America 119 (13) (2022)
Joshua P Dignam, Tara Elizabeth Scott, Barbara K Kemp-Harper, Adrian J Hobbs
Animal models of pulmonary hypertension: Getting to the heart of the problem. British journal of pharmacology (2021)
Philine Marchetta, Lukas Rüttiger, Adrian J Hobbs, Wibke Singer, Marlies Knipper
The role of cGMP signalling in auditory processing in health and disease. British journal of pharmacology (2021)
Robert M H Grange, Michael E J Preedy, Aniruthan Renukanthan, Joshua P Dignam, Vanessa J Lowe, Amie J Moyes, Cristina Pérez-Ternero, Aisah A Aubdool, Reshma S Baliga, Adrian J Hobbs
Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculature. British journal of pharmacology (2021)
Tara Elizabeth Scott, Cheng Xue Qin, Grant R Drummond, Adrian J Hobbs, Barbara K Kemp-Harper
Innovative Anti-Inflammatory and Pro-resolving Strategies for Pulmonary Hypertension: High Blood Pressure Research Council of Australia Award 2019. Hypertension (Dallas, Tex. : 1979) 78 (5) (2021)
Adrian J Hobbs, Amie J Moyes, Reshma S Baliga, Dipa Ghedia, Rachel Ochiel, Yvonne Sylvestre, Caroline J Doré, Kashfia Chowdhury, Kate Maclagan, Harriet L Quartly, Reecha Sofat, Angelique Smit, Benjamin E Schreiber, Gerry J Coghlan, Raymond J MacAllister
Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial. British journal of pharmacology 176 (9) (2019)
Reshma S Baliga, Michael E J Preedy, Matthew S Dukinfield, Sandy M Chu, Aisah A Aubdool, Kristen J Bubb, Amie J Moyes, Michael A Tones, Adrian J Hobbs
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure. Proceedings of the National Academy of Sciences of the United States of America 115 (31) (2018)